Literature DB >> 29221275

Patterns of distant organ metastases in esophageal cancer: a population-based study.

Dashan Ai1,2, Hanting Zhu1,2, Wenjia Ren1,2, Yun Chen1,2, Qi Liu1,2, Jiaying Deng1,2, Jinjun Ye3, Jianhong Fan4, Kuaile Zhao1,2.   

Abstract

BACKGROUND: Esophageal cancer is the eighth most common cancer worldwide. The prognosis of esophageal cancer patients is dismal, especially those with distant organ metastasis. However, there are few studies describing the patterns of distant metastasis in esophageal cancer systematically.
METHODS: We gathered the data from Surveillance Epidemiology and End Results (SEER) database between 2010 and 2013. Categorical variables were analyzed by the Pearson Chi square test, and continuous variables were analyzed by the two-sample t test. Survival estimation and comparison among different variables were performed using Kaplan-Meier method. A multivariable logistic regression model was used to calculate odds ratios (OR) for sex, age, anatomical site, and histological type on specific metastases. Proportional hazards regression model was conducted to obtain adjusted hazard ratio (HRs) for different predictors of overall survival.
RESULTS: A total of 9,934 patients were eligible. Liver was the most common metastatic site in the patients of esophageal cancer and followed by lung, bone and brain. Some clinical features, including age, sex, histology type and histologic grade were independent risk factors for different sites of metastasis. Younger age, poorer differentiation, adenoma type and more metastatic sites might lead to poorer prognosis.
CONCLUSIONS: Our findings revealed the patterns of metastasis in esophageal cancer, which could help clinicians to identify patients with metastasis and provide proper treatment.

Entities:  

Keywords:  Esophageal cancer; Surveillance Epidemiology and End Results (SEER) program; metastatic pattern

Year:  2017        PMID: 29221275      PMCID: PMC5708381          DOI: 10.21037/jtd.2017.08.72

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  14 in total

1.  Validation of a modified GTNM classification in peri-junctional oesophago-gastric carcinoma and its use as a prognostic indicator.

Authors:  G H Dickson; K K Singh; X Escofet; K Kelley
Journal:  Eur J Surg Oncol       Date:  2001-11       Impact factor: 4.424

Review 2.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

Review 3.  Oligometastases revisited.

Authors:  Ralph R Weichselbaum; Samuel Hellman
Journal:  Nat Rev Clin Oncol       Date:  2011-03-22       Impact factor: 66.675

4.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

5.  [Age dependence of metastases. A study of more than 5000 cases of death from cancer].

Authors:  H Barz; D Barz
Journal:  Arch Geschwulstforsch       Date:  1984

6.  Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy.

Authors:  Arjun Pennathur; Andrew Farkas; Alyssa M Krasinskas; Peter F Ferson; William E Gooding; Michael K Gibson; Matthew J Schuchert; Rodney J Landreneau; James D Luketich
Journal:  Ann Thorac Surg       Date:  2009-04       Impact factor: 4.330

7.  Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie.

Authors:  S Lorenzen; T Schuster; R Porschen; S-E Al-Batran; R Hofheinz; P Thuss-Patience; M Moehler; P Grabowski; D Arnold; T Greten; L Müller; N Röthling; C Peschel; R Langer; F Lordick
Journal:  Ann Oncol       Date:  2009-06-23       Impact factor: 32.976

8.  HER-2/neu: a differentiation marker in adenocarcinoma of the esophagus.

Authors:  E R Sauter; S M Keller; S Erner; M Goldberg
Journal:  Cancer Lett       Date:  1993-11-30       Impact factor: 8.679

9.  Worldwide esophageal cancer collaboration.

Authors:  T W Rice; V W Rusch; C Apperson-Hansen; M S Allen; L-Q Chen; J G Hunter; K A Kesler; S Law; T E M R Lerut; C E Reed; J A Salo; W J Scott; S G Swisher; T J Watson; E H Blackstone
Journal:  Dis Esophagus       Date:  2009       Impact factor: 3.429

10.  Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer.

Authors:  S Petrasch; A Welt; A Reinacher; U Graeven; M König; W Schmiegel
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

View more
  29 in total

1.  Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain.

Authors:  Tamar B Nobel; Nikita Dave; Mahmoud Eljalby; Xinxin Xing; Arianna Barbetta; Meier Hsu; Kay See Tan; Yelena Janjigian; Manjit S Bains; Smita Sihag; David R Jones; Daniela Molena
Journal:  Ann Thorac Surg       Date:  2019-10-12       Impact factor: 4.330

Review 2.  Accuracy of endoscopic ultrasound in esophageal cancer staging.

Authors:  Timothy Krill; Michelle Baliss; Russel Roark; Michael Sydor; Ronald Samuel; Jenine Zaibaq; Praveen Guturu; Sreeram Parupudi
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

3.  Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment.

Authors:  Mingxin Zhang; Manli Cui; Qianqian Zuo; Li Wang; Jia Wang; Lin Zhu; Rong Yan; Ning Lu; Honglin Yan; Lingmin Zhang
Journal:  J Gastrointest Oncol       Date:  2021-08

4.  Treatment paradigms and survival outcomes in esophageal adenocarcinoma with liver metastasis: a retrospective cohort study using the SEER database.

Authors:  Jing Guo; Chang-Yong Tong; Jian-Guang Shi; Xin-Jian Li
Journal:  J Gastrointest Oncol       Date:  2022-06

5.  The effect of tumor locations of esophageal cancer on the metastasis to liver or lung.

Authors:  Dashan Ai; Yun Chen; Qi Liu; Jiaying Deng; Kuaile Zhao
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

6.  Patterns of Distant Metastasis Between Histological Types in Esophageal Cancer.

Authors:  San-Gang Wu; Wen-Wen Zhang; Jia-Yuan Sun; Feng-Yan Li; Qin Lin; Zhen-Yu He
Journal:  Front Oncol       Date:  2018-08-08       Impact factor: 6.244

7.  Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study.

Authors:  Jiahua Lyu; Tao Li; Qifeng Wang; Fang Li; Peng Diao; Li Liu; Churong Li; Jinyi Lang
Journal:  Radiat Oncol       Date:  2018-11-26       Impact factor: 3.481

Review 8.  Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.

Authors:  Jin-On Jung; Henrik Nienhüser; Nikolai Schleussner; Thomas Schmidt
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

9.  Hepatic Metastasis in Newly Diagnosed Esophageal Cancer: A Population-Based Study.

Authors:  Huawei Li; Shengqiang Zhang; Jida Guo; Linyou Zhang
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

10.  CircRNA CircRIMS is Overexpressed in Esophageal Squamous Cell Carcinoma and Downregulate miR-613 Through Methylation to Increase Cell Proliferation.

Authors:  Haijun Wan; Bosi Yuan; Kang Jiang; Juan Wei; Xiaoyue Feng; Bo Sun; Fangyu Wang
Journal:  Cancer Manag Res       Date:  2021-06-09       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.